Technology Symposium: AI at the Intersection of Technology and Life Sciences 2026

Join MTC for a half-day technology symposium bringing together technology leaders, life sciences innovators, investors, entrepreneurs, and emerging talent to explore how AI is transforming healthcare and biotechnology. The program will feature a keynote address from Mark Gustavson, Senior Director, Computational Pathology, AstraZeneca where he leads QCS commercialization, along with a student case study and two engaging panel discussions: Investing in the AI-Powered Life Sciences Ecosystem --- Explore where AI is creating measurable value across biotechnology and how AI may serve as both a tailwind and headwind for the industry. AI in Action: Real-World Applications Across Life Sciences --- Hear from life sciences leaders about how AI is being applied in practice and its impact on the industry. Continental Breakfast, Buffet Lunch, and Networking included.